U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07042113) titled 'A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China' on June 09.
Brief Summary: The main purpose of this study is to compare two different formulations (mixtures) of 611 in healthy participants. This study will compare how much of each formulation gets into the blood stream.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DRUG: new formulations of 611
Subjects will receive new formulations of 611 300mg once subcutaneous injection on D1
DRUG: existing formulations of 611
Subjects will receive existing formulations of 611 300mg once subcutaneous in...